Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated financial results of the Company for the quarter and half year ended September 30, 2026

October 22, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeebhoy Towers B andra Kurla Complex, Dalal Street, B(SaYnMdrBaO (EL:) ,T MHuYmRbOaCi A- R40E0) 05 1 (MSCuRmIPba Ci-O 4D0E0: 050319 871) Sub: Prior Intimation of Board Meeting to be held on Thursday, October 29, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/Madam, inter-alia We wish to inform you that a meeting of the Board of Directors of the Company isscheduled to be held on Thursday, October 29, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026. We would also like to inform you that the trading window has been closed from October 01, 2026, for dealing in the securities of the Company by the Designated Persons and their immediate relatives, pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and the Company’s internal code of conduct to regulate, monitor and report trading by Designated Persons and their immediate relatives. The trading window shall reopen 48 hours after declaration of the Unaudited financial results for the quarter and half year ended September 30, 2026. ThisT ihs yforro ycoaurer iTnefocrhmnoatlioogni easn Ldi rmecitoerdd s. F or Brijesh Kumar Company Secretary and Compliance Officer